Carter Boisfontaine (President): $500M+ in transactions, in both VC investments and fundraising for startups. At Pegasus Tech Ventures, which has $2B in AUM and 40+ corporate partners, Carter led their $1B growth fund with the founding partner. At Bird Global, Carter and his Corporate Development team played a pivotal role in closing $200M in private financing, a $150M Apollo debt facility, a SPAC deal, and managing two acquisitions.

Tom has founded 17 companies, 7 of which had >$1B exits.

Highlights include: Cytyc, which automates cytology laboratories; Exact Sciences, creator of Cologaurd (NASDAQ:EXAS); Health Dialog, acquired by Rite-Aid; HNC Software, acquired by Fair Isaac Corporation; Retek, acquired by Oracle; and Saf-T-Med, acquired by Becton Dickinson. Tom is currently the CEO of Thrive Bioscience, which sells non-competing instrumentation to biopharma.

18 years of experience developing tech to improve genetic tests. He developed a biothreat detection system for the BioWatch Program (U.S. Dept of Homeland Security). At QuantaLife, he helped launch ddPCR - acquired by Bio-Rad for $162M.

A veteran of Lonza and serial entrepreneur. Bill founded Sentinel Monitoring, a microbial detection company acquired by Suez (later Veolia). He brings decades of industry experience, trusted relationships, and a proven track record of commercializing microbial detection platforms.